Johnson & Johnson Consumer Inc.

Mcneil Ab

Mcneil-ppc, Inc.

Nicklasson, Fredrik

Katarina Lindell

Leo B Kriksunov

Harry S Sowden

Frank J Bunick

Jen-Chi Chen

Joseph R Luber

Gregory E Koll

Salih Muhsin Muhammed

Mikael Bisrat

Lee Kelepouris

Andreas Hugerth

Fredrik Nicklasson

Kristina Thyresson

Jill Nilgard

Roland Olsson

Carina Siversson

Martin Edman

Gerard McNally

Sofi Nöjd

Nils-Olof Lindberg

Per Steen

Darek Dymitrowicz

Anette Schluter

Asa Waltermo

Magnus Palsson

Darek Dymitrowics

ÅSa Waltermo

Magnus PÅLSSON

Anette SCHLÜTER

Bengt Bosson

John Hendenstrom

Gunnar Bergengren

Anette Schlueter

Christopher E Szymczak

Joe Luber

Salih Mushin Muhammed

The invention relates to a nicotine chewing gum giving an immediate release and uptake of nicotine as well as an extended release and uptake of nicotine as well as describing suitable manufacturing processes for such chewing gum formulations and the use of the chewing gum for the treatment of a human being suffering from cravings from tobacco and/or e-cigarette dependency.

Product and manufacturing process for a gum

The invention relates to a chewing gum comprising at least a gum core comprising nicotine polacrilex, at least a one outer coating covering the core, comprising at least one sugar alcohol or mixtures of sugar alcohols and, at least a one portion fused onto the outer coating, wherein the portion comprises nicotine bitartrate or nicotine ditartrate dihydrate and at least one sugar alcohol or a mixture of sugar alcohols and at least one buffer present in the coating and/or in a portion fused to the coating.

Chewing gum comprising nicotine

A liquid oral pharmaceutical dosage form, comprising pharmacologically effective amounts of at least one histamine H2-receptor antagonist in a hydrophobic/lipophilic liquid substantially free from water comprising at least one viscosity enhancing agent, and pharmacologically effective amounts of one or more antacid(s) in a liquid comprising at least one viscosity enhancing agent and at least one flavor, wherein the two liquids are physically separated from each other and wherein the two liquids have matching rheological profiles and a package comprising multiple liquid oral dosage forms as well as a method of treating a gastric disease or disorder by use of the liquid oral pharmaceutical dosage form.

Liquid oral pharmaceutical dosage form

The invention relates to a lozenge comprising micronized benzocaine, at least one dissolution enhancer and one or more excipients as well as the use of the lozenge for the treatment of sore throat.

Lozenge comprising micronized benzocaine and polyethylene glycol

Growing community of inventors

Eslöv, Sweden

Katarina Lindell